Lord, Abbett & Co. LLC Global Blood Therapeutics, Inc. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$39.6 - $65.9 $2.64 Million - $4.4 Million	-66,702 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$29.7 - $45.7 $2.04 Million - $3.14 Million	-68,809 Reduced 50.78%	66,702 $2.63 Million
Q3 2017 Nov 14, 2017	SELL	$25.1 - $31.05 $9.64 Million - $11.9 Million	-384,111 Reduced 73.92%	135,511 $4.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	519,622	519,622 $14.2 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.